{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:49:47Z","timestamp":1780634987859,"version":"3.54.1"},"reference-count":33,"publisher":"Portland Press Ltd.","issue":"24","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Liver cirrhosis and portal hypertension is the end of chronic liver injury with hepatic, splanchnic and portosystemic collateral systems dysregulation. Liver injury is accompanied by gut dysbiosis whereas dysbiosis induces liver fibrosis, splanchnic angiogenesis and dysregulated vascular tones vice versa, making portal hypertension aggravated. It has been proved that intestinal microbiota transplantation alleviates dysbiosis. Nevertheless, the influences of microbiota transplantation on cirrhosis-related portal hypertension are not so clear. Liver cirrhosis with portal hypertension was induced by bile duct ligation (BDL) in rats. Sham rats were surgical controls. Rats randomly received vehicle, fecal or gut (terminal ileum) material transplantation. The results showed that microbiota transplantation from feces or gut material significantly reduced portal pressure in cirrhotic rats (P=0.010, 0.044). Hepatic resistance, vascular contractility, fibrosis and relevant protein expressions were not significantly different among cirrhotic rats. However, microbiota transplantation ameliorated splanchnic hyperdynamic flow and vasodilatation. Mesenteric angiogenesis, defined by whole mesenteric window vascular density, decreased in both transplantation groups and phosphorylated endothelial nitric-oxide synthase (eNOS) was down-regulated. Portosystemic shunts determined by splenorenal shunt (SRS) flow decreased in both transplantation groups (P=0.037, 0.032). Shunting severity assessed by microsphere distribution method showed consistent results. Compared with sham rats, cirrhotic rats lacked Lachnospiraceae. Both microbiota transplants increased Bifidobacterium. In conclusion, microbiota transplantation in cirrhotic rats reduced portal pressure, alleviated splanchnic hyperdynamic circulation and portosystemic shunts. The main beneficial effects may be focused on portosystemic collaterals-related events, such as hepatic encephalopathy and gastroesophageal variceal hemorrhage. Further clinical investigations are mandatory.<\/jats:p>","DOI":"10.1042\/cs20210602","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T12:46:28Z","timestamp":1638794788000},"page":"2709-2728","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats"],"prefix":"10.1042","volume":"135","author":[{"given":"Hui-Chun","family":"Huang","sequence":"first","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hung","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chih","family":"Chang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chon\u00a0Kit","family":"Pun","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Yauh","family":"Lee","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-634X","authenticated-orcid":false,"given":"Shao-Jung","family":"Hsu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"2021121510162157200_B1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2021121510162157200_B2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2021121510162157200_B3","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","article-title":"Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis","volume":"72","author":"Praktiknjo","year":"2020","journal-title":"J. Hepatol."},{"key":"2021121510162157200_B4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J. Hepatol."},{"key":"2021121510162157200_B5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","article-title":"Altered microbiome in patients with cirrhosis and complications","volume":"17","author":"Acharya","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2021121510162157200_B6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J. Hepatol."},{"key":"2021121510162157200_B7","doi-asserted-by":"publisher","first-page":"613.e9","DOI":"10.1053\/j.gastro.2012.11.005","article-title":"Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis","volume":"144","author":"Schirbel","year":"2013","journal-title":"Gastroenterology"},{"key":"2021121510162157200_B8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2021121510162157200_B9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"2021121510162157200_B10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"2021121510162157200_B11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jhep.2020.01.017","article-title":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis","volume":"72","author":"Bajaj","year":"2020","journal-title":"J. Hepatol."},{"key":"2021121510162157200_B12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/hep.30349","article-title":"Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis","volume":"70","author":"Mu\u00f1oz","year":"2019","journal-title":"Hepatology"},{"key":"2021121510162157200_B13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease - a practical approach for translational research","volume":"73","author":"Nevzorova","year":"2020","journal-title":"J. Hepatol."},{"key":"2021121510162157200_B14","doi-asserted-by":"publisher","first-page":"e0134893","DOI":"10.1371\/journal.pone.0134893","article-title":"Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity","volume":"10","author":"Di Luccia","year":"2015","journal-title":"PLoS ONE"},{"key":"2021121510162157200_B15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.115.06672","article-title":"Role of the gut microbiome in obstructive sleep apnea-induced hypertension","volume":"67","author":"Durgan","year":"2016","journal-title":"Hypertension"},{"key":"2021121510162157200_B16","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/hep.27679","article-title":"Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats","volume":"61","author":"Hsu","year":"2015","journal-title":"Hepatology"},{"key":"2021121510162157200_B17","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.gastro.2003.07.014","article-title":"Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats","volume":"125","author":"Tsai","year":"2003","journal-title":"Gastroenterology"},{"key":"2021121510162157200_B18","doi-asserted-by":"publisher","first-page":"G544","DOI":"10.1152\/ajpgi.1992.263.4.G544","article-title":"Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium","volume":"263","author":"Mosca","year":"1992","journal-title":"Am. J. Physiol."},{"key":"2021121510162157200_B19","doi-asserted-by":"publisher","first-page":"G371","DOI":"10.1152\/ajpgi.1981.240.5.G371","article-title":"Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres","volume":"240","author":"Chojkier","year":"1981","journal-title":"Am. J. Physiol."},{"key":"2021121510162157200_B20","doi-asserted-by":"publisher","first-page":"H1150","DOI":"10.1152\/ajpheart.1999.276.4.H1150","article-title":"On the validity of blood flow measurement using colored microspheres","volume":"276","author":"Hodeige","year":"1999","journal-title":"Am. J. Physiol."},{"key":"2021121510162157200_B21","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/aem.63.7.2802-2813.1997","article-title":"Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis","volume":"63","author":"Godon","year":"1997","journal-title":"Appl. Environ. Microbiol."},{"key":"2021121510162157200_B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int."},{"key":"2021121510162157200_B23","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda-Lezana","year":"2018","journal-title":"Hepatology"},{"key":"2021121510162157200_B24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/liv.13986","article-title":"Potential mechanisms linking gut microbiota and portal hypertension","volume":"39","author":"Baffy","year":"2019","journal-title":"Liver Int."},{"key":"2021121510162157200_B25","doi-asserted-by":"publisher","first-page":"1921.e3","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"key":"2021121510162157200_B26","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/0016-5085(93)90152-3","article-title":"Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats","volume":"105","author":"Lee","year":"1993","journal-title":"Gastroenterology"},{"key":"2021121510162157200_B27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2003.12.012","article-title":"Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice","volume":"126","author":"Fernandez","year":"2004","journal-title":"Gastroenterology"},{"key":"2021121510162157200_B28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/hep.25625","article-title":"Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats","volume":"56","author":"Huang","year":"2012","journal-title":"Hepatology"},{"key":"2021121510162157200_B29","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/JCI119868","article-title":"Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells","volume":"100","author":"Papapetropoulos","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2021121510162157200_B30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"Nitric oxide in liver diseases","volume":"36","author":"Iwakiri","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"2021121510162157200_B31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4939-9420-5_15","article-title":"Common bile duct ligation as model for secondary biliary cirrhosis","volume":"1981","author":"Van Campenhout","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"2021121510162157200_B32","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"key":"2021121510162157200_B33","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.3748\/wjg.v12.i41.6577","article-title":"Animal models of portal hypertension","volume":"12","author":"Abraldes","year":"2006","journal-title":"World J. Gastroenterol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/24\/2709\/926386\/cs-2021-0602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/24\/2709\/926386\/cs-2021-0602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T10:23:09Z","timestamp":1639563789000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/24\/2709\/230370\/Microbiota-transplants-from-feces-or-gut-content"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12,22]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20210602","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,12]]}}}